ARTICLE | Company News
Genomics deal by GPC and Boehringer
January 9, 2001 8:00 AM UTC
GPC Biotech (NMarkt:GPC) signed a license and research deal to provide Boehringer Ingelheim (Ingelheim, Germany) with targets and molecular pathways associated with human papillomavirus (HPV) infectio...